ImmunoPrecise Antibodies Ltd. Discusses Target Customer Base and Growth Drivers in an Interview with StockNewsNow

ImmunoPrecise’s CEO and President, Dr. Jennifer Bath spoke with SNNLive at the SmallCap Discoveries Conference 2018 in Vancouver.

Check Out the Video to Find out More On:

The overview and history of ImmunoPrecise Antibodies, what makes IPA unique in the marketplace, target customer base, the challenges pharmaceutical companies face when going through the process of outsourcing their pharmaceutical drug discovery, Dr. Bath’s background, and growth drivers.

About is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.